Castle Biosciences Incorporated - Product Pipeline Analysis

1
Castle Biosciences Incorporated - Product
Pipeline AnalysisMarket Research Reports
Distributor - Aarkstore.com have vast database on
market research reports, company financials,
company profiles, SWOT analysis, company report,
company statistics, strategy review, industry
report, industry research to provide excellent
and innovative service to our report
buyers.Aarkstore.com have very interactive
search feature to browse across more than
2,50,000 business industry reports. We are built
on the premise that reading is valuable, capable
of stirring emotions and firing the imagination.
Whether you're looking for new market research
report product trends or competitive industry
analysis of a new or existing market,
Aarkstore.com has the best resource offerings and
the expertise to make sure you get the right
product every time.
2
Castle Biosciences Incorporated - Product
Pipeline Analysis

• SummaryCastle Biosciences Incorporated (Castle
  Biosciences) is a cancer diagnostics company. The
  company works with cancer institution to in
  license propietary technologies and complete
  development and validation. Castle Biosciences
  product include DecisionDx-UM test. The
  DecisionDx-UM test measures the gene expression
  profile, also called GEP or molecular signature
  of an individuals tumor and identifies the
  likelihood of metastasis. The compay is
  headqutered in Texas, the US.This report is a
  source for data, analysis and actionable
  intelligence on the Castle Biosciences
  Incorporated portfolio of pipeline products. The
  report provides detailed analysis on each
  pipeline product with information on the
  indication, the development stage, trial phase,
  product milestones, pipeline territory, estimated
  approval date, and estimated launch dateEach
  pipeline product is profiled to cover information
  on product description, function, technology,
  indication, and application. The report is also
  supplemented with a detailed company profile and
  information on clinical trials, wherever
  applicable.This report is built using data and
  information sourced from proprietary databases,
  primary and secondary research and in-house
  analysis by GlobalDatas team of industry experts.

3

• Scope- Detailed company profile with
  information on business description, key company
  facts, major products and services, key
  competitors, key employees, locations and
  subsidiaries and recent developments.- Detailed
  coverage on all the pipeline products, by
  equipment type, by therapy area, by development
  stage, and by trial phase.- Information on
  product milestones and pipeline territory for
  each product, the estimated approval date, and
  estimated launch date.- Profile of each pipeline
  product with additional information on product
  description, function, technology, indication(s),
  and application.- Data on relevant clinical
  trials and product patent details, wherever
  applicable.- Information on clinical trial,
  wherever applicable, is supplemented with
  information on trial phase, trial status, trial
  objective, trial design, target patients, unique
  physician identifier, primary point, secondary
  point, acronym, participants inclusion,
  participants exclusion, interventions, trial
  results, trial start date, trial end date, study
  type, trial site, trial funding, age eligibility,
  and gender eligibility.
• Reasons to Buy- Develop business strategies by
  understanding the trends and developments driving
  the medical devices pipeline and technology
  landscape globally.- Design and develop your
  product development, marketing and sales
  strategies.- Exploit MA opportunities by
  identifying market players with the most
  innovative pipeline.- Develop market-entry and
  market expansion strategies.- Exploit
  in-licensing and out-licensing opportunities by
  identifying products, most likely to ensure a
  robust return.- Identify emerging players with
  potentially strong product portfolio and create
  effective counter-strategies to gain competitive
  advantage.- Develop competition strategies by
  identifying the status and likely launch of your
  competitors pipeline products through review of
  the clinical trials, stage and phase of
  development, etc.- Which are the next high-value
  products that your competitor would add in its
  portfolio? identify, understand and capitalize.

4

• List of Tables 3List of Figures 3Key Facts
  4Castle Biosciences Incorporated - Major
  Products and Services 5Castle Biosciences
  Incorporated Pipeline Products by Equipment Type
  6Castle Biosciences Incorporated Pipeline
  Products by Development Stage 8Castle
  Biosciences Incorporated Pipeline Products by
  Therapy Area 10DecisionDx-EC 12DecisionDx-EC
  Product Status 12DecisionDx-EC Product
  Description 12DecisionDx-GBM Biomarker Panel
  13DecisionDx-GBM Biomarker Panel Product Status
  13DecisionDx-GBM Biomarker Panel Product
  Description 13DecisionDx-LEA 14DecisionDx-LEA
  Product Status 14DecisionDx-LEA Product
  Description 14DecisionDx-LGG Biomarker Panel
  15DecisionDx-LGG Biomarker Panel Product Status
  15DecisionDx-LGG Biomarker Panel Product
  Description 15DecisionDx-Thymoma
  16DecisionDx-Thymoma Product Status
  16DecisionDx-Thymoma Product Description
  16DecisionDx-UM Biomarker Panel 17DecisionDx-UM
  Biomarker Panel Product Status 17DecisionDx-UM
  Biomarker Panel Product Description 17Castle
  Biosciences Incorporated - Key Employees
  18Castle Biosciences Incorporated - Locations
  And Subsidiaries 19Head Office 19Recent
  Developments 20Castle Biosciences Incorporated,
  Recent Developments 20Apr 11, 2012 RiboMed
  Launches Improved Prognostic Multi Biomarker
  Epigenetic Test For Brain Cancer 20Appendix
  21Methodology 21About GlobalData 21Contact Us
  21Disclaimer 21

5

• List of Tables Castle Biosciences Incorporated,
  Key Facts 1Castle Biosciences Incorporated Key
  Pipeline Products by Equipment Type 1Castle
  Biosciences Incorporated Key Pipeline Products by
  Therapy Area 1Castle Biosciences Incorporated
  Key Pipeline Products by Development Stage
  1Castle Biosciences Incorporated, Key Facts
  4Castle Biosciences Incorporated, Major Products
  and Services 5Castle Biosciences Incorporated
  Number of Pipeline Products by Equipment Type
  6Castle Biosciences Incorporated Pipeline
  Products by Equipment Type 7Castle Biosciences
  Incorporated Number of Pipeline Products by
  Development Stage 8Castle Biosciences
  Incorporated Pipeline Products by Development
  Stage 9Castle Biosciences Incorporated Number of
  Pipeline Products by Therapy Area 10Castle
  Biosciences Incorporated Pipeline Products by
  Therapy Area 11DecisionDx-EC - Product Status
  12DecisionDx-EC - Product Description
  12DecisionDx-GBM Biomarker Panel - Product
  Status 13DecisionDx-GBM Biomarker Panel -
  Product Description 13DecisionDx-LEA - Product
  Status 14DecisionDx-LEA - Product Description
  14DecisionDx-LGG Biomarker Panel - Product
  Status 15DecisionDx-LGG Biomarker Panel -
  Product Description 15DecisionDx-Thymoma -
  Product Status 16DecisionDx-Thymoma - Product
  Description 16DecisionDx-UM Biomarker Panel -
  Product Status 17DecisionDx-UM Biomarker Panel -
  Product Description 17Castle Biosciences
  Incorporated, Key Employees 18

6
List of Figures Castle Biosciences
Incorporated Pipeline Products by Equipment Type
6Castle Biosciences Incorporated Pipeline
Products by Development Stage 8Castle
Biosciences Incorporated Pipeline Products by
Therapy Area 10 
7

• For more information, please visit
• http//www.aarkstore.com/reports/Castle-Bioscience
  s-Incorporated-Product-Pipeline-Analysis
• 240137.html
• Or email us at contact_at_aarkstore.com or call
  919272852585
• http//www.aarkstore.com/search/viewresults.asp?se
  archProduct20Pipeline20AnalysisPubId
• pagenum1
• Related Reports
• 2013 French Hospital Hematology and Flow
  Cytometry Market
• United Arab Emirates In Vitro Diagnostics
  Investment Opportunities, Analysis and Forecasts
  to 2018
• Chile In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Norway In Vitro Diagnostics Investment
  Opportunities, Analysis and Forecasts to 2018
• Aleva Neurotherapeutics SA - Product Pipeline
  Analysis.
• DiaPat GmbH - Product Pipeline Analysis.
• Manhattan Scientifics, Inc. (MHTX) - Product
  Pipeline Analysis.

8

• Contact Us
• Aarkstore Enterprise
• Tel [phone]
• Mobile No08149852585
• Email contact_at_aarkstore.com
• Website http//www.aarkstore.com
• Blog http//www.emarketreports.com
• http//teju-aarkstoreenterprise.blogspot.in
• Follow us on twitter http//twitter.com/aarkstore
  dotcom
• http//in.linkedin.com/in/aarkstore
• http//www.facebook.com/aarkstoreenterprise